Ocotillol Derivatives Mitigate Retinal Ischemia-Reperfusion Injury by Regulating the Keap1/Nrf2/ARE Signaling Pathway
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00867 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Xin Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Kelch-Like ECH-Associated Protein 1, Reperfusion Injury, Signal Transduction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Taishan Scholar Project of Shandong Province, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Retinal ischemia-reperfusion (RIR) injury can lead to various retinal diseases. Oxidative stress is considered an important pathological event in RIR injury. Here, we designed and synthesized 34 ocotillol derivatives, then examined their antioxidant and anti-inflammatory capacities; we found that compounds 7 (C24-R) and 8 (C24-S) were most active. To enhance their water solubility, sustained release, and biocompatibility, compounds 7 and 8 were encapsulated into liposomes for in vivo activity and mechanistic studies. In vivo studies indicated that compounds 7 and 8 protected normal retinal structure and physiological function after RIR injury, reversed damage to retinal ganglion cells, and the S-configuration exhibited significantly stronger activity compared with the R-configuration. Mechanistic studies showed that compound 8 exerted a therapeutic effect on RIR injury by activating the Keap1/Nrf2/ARE signaling pathway; compound 7 did not influence this pathway. We also demonstrated that differential isomerization at the C-24 position influenced protection against RIR injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universi…
ORCID-Profile: Yi Bi
Förderung
- Taishan Scholar Project of Shandong Province
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- College Students Innovation and Entrepreneurship Training Program
- Yantai Science and Technology Innovation Development Plan
- The Science and Technology Support Program for Youth Innovation in Universities of Shandong
Zitieren
APA
Zhang, X., Zhang, W., Zhao, L., Ma, G., Huang, Y., Geng, Z., Jiang, Q., Wen, X., Lin, Y., Meng, Q., Zhang, Z., & Bi, Y. (2024). Ocotillol Derivatives Mitigate Retinal Ischemia-Reperfusion Injury by Regulating the Keap1/Nrf2/ARE Signaling Pathway. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00867
Vancouver
Zhang X, Zhang W, Zhao L, Ma G, Huang Y, Geng Z, et al. Ocotillol Derivatives Mitigate Retinal Ischemia-Reperfusion Injury by Regulating the Keap1/Nrf2/ARE Signaling Pathway. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00867
BibTeX
@article{Zhang2024,
author = {Zhang, Xin and Zhang, Wen and Zhao, Laien and Ma, Gongshan and Huang, Yanmei and Geng, Zhiyuan and Jiang, Qian and Wen, Xiaomei and Lin, Yuqi and Meng, Qingguo and Zhang, Zhuhong and Bi, Yi},
title = {Ocotillol Derivatives Mitigate Retinal Ischemia-Reperfusion Injury by Regulating the Keap1/Nrf2/ARE Signaling Pathway},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00867}
}
EUVIMED